Hanwu Zhiyuan (Nanjing) Biomedical Technology Co., Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hanwu Zhiyuan (Nanjing) Biomedical Technology Co., Ltd - overview
Established
2022
Location
Nanjing, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Nanjing, China, and founded in 2022, Hanwu Zhiyuan (Nanjing) Biomedical Technology Co. , Ltd operates as a biopharmaceutical company that provides central nervous system drugs. As of 2022, the company completed a round of financing. The company focuses on the discovery and development of drugs for the central nervous system by creating an intelligent and high-content screening platform.
Its core technology platform is based on neural networks cultured from adult stem cells (ASCs).
Current Investors
Yingdi Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.